CVAC Competitors & Alternatives
Compare CureVac NV with similar stocks in the same industry
Biotechnology
CVAC
Main Stock$4.66
Tradestie Score
58
Market Cap
$1.22B
P/E Ratio
7.0
Revenue Growth
-0.9%
Analyst Upside
+15.6%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$7.07
|
$1.12B | - | 54 | Compare |
|
NKTR
Nektar Therapeutics
|
$82.67
|
$1.12B | - | 54 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$317.74
|
$1.12B | - | 58 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$11.12
|
$1.09B | - | 60 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$16.49
|
$1.05B | 423.0 | 51 | Compare |
|
UPB
Upstream Bio, Inc. Common Stock
|
$9.03
|
$1.00B | - | 58 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$7.76
|
$997.16M | - | 59 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.53
|
$996.55M | - | 51 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$70.45
|
$994.20M | - | 58 | Compare |
|
IMNM
Immunome, Inc.
|
$22.85
|
$987.09M | - | 55 | Compare |
More CVAC Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry